<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>HYPOTHESIS: Stage I or II colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> with microsatellite instability (MSI) are characterized by more isolated lymph nodes in the resected specimen than their counterparts with microsatellite stability (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Prospective study </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Academic research </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: Using a pentaplex polymerase chain reaction assay, MSI status was determined prospectively for 135 operative patients </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: Mismatch repair defects were investigated by immunohistochemistry on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> demonstrating MSI </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among 82 stage I or II colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, 11 had MSI, and 71 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>, with a mean (SD) number of 23.6 (3.1) and 13.7 (1.0) negative lymph nodes, respectively (P = .001) </plain></SENT>
<SENT sid="6" pm="."><plain>The mean number of lymph nodes for <z:hpo ids='HP_0000001'>all</z:hpo> resected stage I or II colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> analyzed at our hospital was 15 </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence of MSI among <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with more than 15 lymph nodes in the specimen was 25% (9 of 36), and 82% (9 of 11) of MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> belonged to this group </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: A high number of isolated lymph nodes in stage I or II colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> was associated with the MSI phenotype </plain></SENT>
<SENT sid="9" pm="."><plain>Good prognosis that is usually associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> having a high number of uninvolved lymph nodes might reflect the high prevalence of MSI among these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The number of examined lymph nodes as a quality criterion should be used with caution </plain></SENT>
<SENT sid="11" pm="."><plain>For stage I or stage II colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, restricting MSI phenotyping to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with more than the mean number of lymph nodes identifies almost <z:hpo ids='HP_0000001'>all</z:hpo> MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>